The Food and Drug Administration is signaling a major shift in federal policy on who may donate blood, proposing guidelines that would eliminate the existing time-based blood donation deferrals for men who have sex with men and women who have sex with those individuals. Instead, FDA is proposing that blood donor eligibility would be assessed using gender-inclusive, individual risk-based questions to reduce the risk of transfusion-transmitted HIV. The policy shift is one that AHA has long advocated for, in part due to the significant strain on the nation’s blood supply in the post-COVID-19 pandemic landscape

Related News Articles

Headline
The Food and Drug Administration May 11 finalized revised recommendations for assessing blood donor eligibility, which use the same risk-based questions for…
Headline
AHA today applauded and urged the Food and Drug Administration to finalize its draft guidance proposing that blood donor eligibility be determined based…
Headline
The international division of America’s Blood Centers recently launched a website to connect blood donors with donation sites. The site also includes…
Headline
The Department of Health and Human Services yesterday launched Giving = Living, a campaign to encourage Americans to donate blood and plasma regularly. Funded…
News
Americas Blood Centers Friday released a bulletin on blood shortages and how hospitals and their clinicians can help, from implementing certain transfusion and…
Headline
A shortage of BioFlex blood bags made by Fresenius Kabi is impacting an estimated 10%-15% of whole blood collections, America’s Blood Centers and Blood Centers…